Citi: In a scenario where GLP-1s benefit a large number of people, there could be a gradual increase in the available labor force due to reduction in musculoskeletal issues and chronic diseases, boosting both GDP and tax revenue. Whats more, a Goldman Sachs analysis from earlier this year estimates that GLP-1 drugs could boost GDP by 0.4 percent in its baseline scenario, with potential gains up to one percent in its upside case
Reference lists of studies and reviews identified on the topic were searched to identify additional publications
Less common but serious side effects include pancreatitis, increased heart rate, and kidney problems, all requiring immediate medical attention
Consistent with the trends observed for C max , a higher semaglutide dose yielded higher C steady-state values, whereby the S-1.2 mg 2-10 and S-0.6 mg 2-10 formulations achieved steady-state serum concentrations of 75 10 ng/mL and 66 50 ng/mL, respectively ( P = 0.8, Table S2 and S4)
What triggers one person may be perfectly fine for another
They involve different dosing protocols and absorption characteristics compared to injectables
)
)
